Response by Bonnesen et al to Letter Regarding Article, “Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation”

K Kasper Bonnesen (Department of Clinical Epidemiology, Aarhus University Hospital, Denmark (K.B. U.H-J., M.S.).) U Uffe Heide-Jørgensen (Department of Clinical Epidemiology, Aarhus University Hospital, Denmark (K.B. U.H-J., M.S.).) M Morten Schmidt (Department of Clinical Epidemiology, Aarhus University Hospital, Denmark (K.B. U.H-J., M.S.).)

Article Details

Journal Circulation
Volume / Issue Vol. 151, Issue 17
Published April 29, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (3)

K

Kasper Bonnesen

Department of Clinical Epidemiology, Aarhus University Hospital, Denmark (K.B. U.H-J., M.S.).

U

Uffe Heide-Jørgensen

Department of Clinical Epidemiology, Aarhus University Hospital, Denmark (K.B. U.H-J., M.S.).

M

Morten Schmidt

Department of Clinical Epidemiology, Aarhus University Hospital, Denmark (K.B. U.H-J., M.S.).